Do Microcurrent Facial Devices Work, the Studies and What They Measured
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
The evidence supports skin-level effects from microcurrent and muscle-level change from currents about twenty times stronger, and most brands blur the difference between the two.
This article explains what is actually happening, such as:
- what each of the commonly cited studies actually measured
- the study that found no benefit, and why it matters
- why a study on one device does not transfer to another
- the gap between microamps and the currents used in the research
- what you can reasonably expect from a device you can buy
and many more!
We cite the study that disagrees with us, because a citation list with no disagreement in it is advertising.
Key Points:
Kavanagh 2012 measured an 18.6 percent increase in cheek muscle thickness in 108 women over twelve weeks, using motor-level stimulation rather than microcurrent.
Chang 2020 ran a double-blind sham-controlled trial of facial stimulation over six weeks.
Kwak 2023 ran both bands on one face and found microcurrent improved eye-wrinkle volume and dermal density while the stronger side improved lifting measures.
Papaiordanidou 2014 found stimulation protocols that produced fatigue rather than benefit, which is the study most brands leave out.
Almost no trial tests a specific consumer device, so a citation supports a mechanism rather than a product.
What the four studies measured
Kavanagh and colleagues used ultrasound to measure cheek muscle thickness across 108 women over twelve weeks, and found an 18.6 percent increase (10.1111/jocd.12007). The stimulation was at motor level, meaning the muscle visibly contracted.
Chang and colleagues ran a double-blind sham-controlled design over six weeks, which is the strongest methodology in this set because participants could not tell which group they were in (10.3390/ijerph17113783).
Kwak and colleagues ran a split-face study, microcurrent on one side and motor-level stimulation on the other, and found different benefits on each side (10.52660/jksc.2023.29.6.1505).
Saniee and colleagues examined microcurrent effects on facial skin specifically (10.29252/jmj.10.2.9).
The one that disagrees
Papaiordanidou and colleagues examined stimulation protocols and found conditions where the result was muscle fatigue rather than gain (10.1371/journal.pone.0084740).
That finding is the reason we specify three to five sessions a week rather than daily, and ten minutes rather than twenty.
It is also the study you will almost never see on a competitor's science page, because it complicates the sales argument.
Maffiuletti's work on stimulation parameters points the same way: dose and pattern decide whether stimulation builds or exhausts (PMID 29233625).
Microcurrent against motor level, the distinction that matters
Microcurrent devices run in millionths of an amp. NuFACE files 335 microamps, Therabody publishes 500, FOREO publishes 680, 7E publishes 350 at 500 ohms.
Motor-level stimulation, the kind Kavanagh used, runs in thousandths of an amp, roughly twenty times higher, and produces a visible contraction.
So a brand citing Kavanagh for a 500 microamp device is citing research conducted at a level its device does not reach.
Kwak's split-face design is the cleanest illustration, because one person received both and the two sides improved on different measures.
PureLift publishes 7 mA at 500 ohms on Face and Pro and 9 mA on Pro Plus and GLOW, which is the band the muscle research used.
Why a study does not transfer between devices
Current, frequency, pulse width, waveform and electrode size all differ between devices, and all of them change what reaches tissue.
A trial run on one machine tells you the mechanism can work, not that a particular product delivers it.
Almost no consumer device in this category has been tested in a published trial of its own, ours included, and any brand claiming clinical proof of its specific product should be asked for the citation.
Solawave deserves credit here for stating plainly on its own science page that the studies it references are studies of other devices.
What you can reasonably expect
From microcurrent: skin-level effects, texture, a temporary fresher look, and results measured in appearance rather than in anatomy.
From motor-level stimulation: measurable muscle change over about twelve weeks, and a contraction you can see while using it.
From either: a same-day depuffing effect from moving fluid, which disappears within about a day.
From neither: anything resembling a surgical result, and no device in this category should be implying one.
How to read any brand's evidence page
Check whether the cited study used the same current band as the device being sold.
Check whether the study tested the device or the mechanism.
Check whether a sham or control group existed, since uncontrolled before-and-after in a category this susceptible to expectation means very little.
Check whether any study that disagrees is mentioned at all, which is the fastest test of whether you are reading evidence or marketing.
This comparison sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.
Studies and figures checked on 21 September 2026 against the cited publications and each manufacturer's published specifications.